Bellerophon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BLPH and buy or sell other stocks, ETFs, and their options commission-free!About BLPH
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees—
Employees—
HeadquartersWarren, New Jersey
HeadquartersWarren, New Jersey
Founded2009
Founded2009
Employees—
Employees—
BLPH Key Statistics
Market cap146.80K
Market cap146.80K
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume67.09K
Average volume67.09K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.10
52 Week high$0.10
52 Week low$0.01
52 Week low$0.01
Stock Snapshot
The current Bellerophon Therapeutics(BLPH) stock price is $0.01, with a market capitalization of 146.8K. The stock trades at a price-to-earnings (P/E) ratio of -0.01.
During the trading day, Bellerophon Therapeutics(BLPH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Bellerophon Therapeutics(BLPH) stock has reached 0, versus its average volume of 67.09K.
Over the past 52 weeks, Bellerophon Therapeutics(BLPH) stock has traded between a high of $0.10 and a low of $0.01.
Over the past 52 weeks, Bellerophon Therapeutics(BLPH) stock has traded between a high of $0.10 and a low of $0.01.